摘要
目的分析黄芪治疗对稳定期中重度COPD患者肺功能及生活质量的影响。方法 COPD人群随机分为黄芪治疗组和安慰剂治疗组,观察两组人群治疗前后肺功能及生活质量的变化。结果黄芪治疗组肺功能稳定、SGRQ评分下降,生活质量改善;安慰剂治疗组肺功能进行下降、SGRQ评分增加,生活质量恶化。结论黄芪能够延缓稳定期中重度COPD患者肺功能恶化、改善其生活质量。
Objective To evaluate the effect of astragalus treatment on pulmonary function and quality of life in patients with moderate to severe COPD on the stationary phase. Methods COPD patients were randomly divided into astragalus treatment group and placebo treatment group. The changes of pulmonary function and quality of life before and after treatment in the two groups were observed. Results pulmonary function remained stable and the total score of SGRQ were lower than before treatment in the astragalus group. Quality of life were improved in the astragalus group, pulmonary function decreased significantly and the total score of SGRQ were higher than before treatment in the placebo treatment group. Quality of life were deteriorated in the placebo treatment group. Conclusion Astragalus could delay lung function deterioration and improved quality of life in patients with moderate to severe COPD on the stationary phase.
出处
《中国现代药物应用》
2013年第10期7-8,共2页
Chinese Journal of Modern Drug Application
关键词
慢性阻塞性肺疾病
黄芪
肺功能
Chronic obstructive pulmonary disease
Astragalus
Pulmonary function